Patent Assignment
Reel/Frame 058621/0930
Assignment of Assignor's Interest
Recorded: 2022-01-11
Pages: 4
Assignee
CLOUDBREAK THERAPEUTICS, LLC
15615 ALTON PARKWAY, SUITE 450, IRVINE, CALIFORNIA, 92618
Covered Property
(1)
Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.